Evidence map›Paper›PMID 40027659›Full record

ArticlebioRxiv : the preprint server for biology2025

Biomaterial-based 3D human lung models replicate pathological characteristics of early pulmonary fibrosis.

Alicia E Tanneberger, Rachel Blomberg, Anton D Kary, Andrew Lu, David W H Riches, Chelsea M Magin

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Alicia E TannebergerDepartment of Bioengineering, University of Colorado, Denver | Anschutz Medical Campus, Aurora, CO.ORCID 0000-0002-5552-5045
Rachel BlombergDepartment of Bioengineering, University of Colorado, Denver | Anschutz Medical Campus, Aurora, CO.ORCID 0000-0002-1776-0044
Anton D KaryDepartment of Bioengineering, University of Colorado, Denver | Anschutz Medical Campus, Aurora, CO.ORCID 0009-0005-6188-1846
Andrew LuDepartment of Bioengineering, University of Colorado, Denver | Anschutz Medical Campus, Aurora, CO.
David W H RichesProgram in Cell Biology, Department of Pediatrics, National Jewish Health, Denver, CO.
Chelsea M MaginDepartment of Bioengineering, University of Colorado, Denver | Anschutz Medical Campus, Aurora, CO.ORCID 0000-0002-6988-8584

Funding

Targeting early events in MUC5B-driven lung injury and fibrosisP01HL162607 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI David Albert Schwartz · 2023 to 2026
$12.4M
Cardiovascular Biomechanics and Imaging in Down SyndromeT32HL072738 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI SHANDAS, ROBIN · 2003 to 2025
$4.9M
A National iPS Cell Network with Deep Phenotyping for Translational ResearchU01TR001810 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GILAD, YOAV, KOTTON, DARRELL N. · 2016 to 2020
$4.4M
Hybrid Hydrogel Biomaterials Comprising Clickable Decellularized Extracellular Matrix for Engineering Dynamic 3D Models of FibrosisR01HL153096 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI MAGIN, CHELSEA M · 2020 to 2024
$2.6M
NCATS NIH HHS U01 TR001810NHLBI NIH HHS P01 HL162607NHLBI NIH HHS R01 HL153096NHLBI NIH HHS T32 HL072738
6 · The paper itself

Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive and incurable lung disease characterized by tissue scarring that disrupts gas exchange. Epithelial cell dysfunction, fibroblast activation, and excessive extracellular matrix deposition drive this pathology that ultimately leads to respiratory failure. Mechanistic studies have shown that repeated injury to alveolar epithelial cells initiates an aberrant wound-healing response in surrounding fibroblasts through secretion of mediators like transforming growth factor-β, yet the precise biological pathways contributing to disease progression are not fully understood. To better study these interactions there is a critical need for lung models that replicate the cellular heterogeneity, geometry, and biomechanics of the distal lung microenvironment. In this study, induced pluripotent stem cell-derived alveolar epithelial type II (iATII) cells and human pulmonary fibroblasts were arranged to replicate human lung micro-architecture and embedded in soft or stiff poly(ethylene glycol) norbornene (PEG-NB) hydrogels that recapitulated the mechanical properties of healthy and fibrotic lung tissue, respectively. The co-cultured cells were then exposed to pro-fibrotic biochemical cues, including inflammatory cytokines and growth factors. iATIIs and fibroblasts exhibited differentiation pathways and gene expression patterns consistent with trends observed during IPF progression

Indexed as

3D cell culturebiomaterialsfibroblast activationIdiopathic pulmonary fibrosisinduced pluripotent stem cell-derived alveolar epithelial cellsin vitro models

Identifiers

PMID40027659
PMCPMC11870410

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.